Evidence map›Paper›PMID 26339335›Full record

ArticleInternational journal of clinical and experimental pathology2015

Ulinastatin mediates protection against vascular hyperpermeability following hemorrhagic shock.

Bo Lin, Youtan Liu, Tao Li, Kai Zeng, Shumin Cai, Zhenhua Zeng, Caizhu Lin, Zhongqing Chen, Youguang Gao

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Multi-organ protection of ulinastatin in traumatic cardiac arrest model.World journal of emergency surgery : WJES · 2018
    Article
  7. Article
  8. Cryptdin-2 predicts intestinal injury during heatstroke in mice.International journal of molecular medicine · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Bo LinDepartment of Anesthesiology, The First Affiliated Hospital of Fujian Medical University Fuzhou 350005, China.
Youtan LiuDepartment of Anesthesiology, Shenzhen Hospital, Soutern Medical University Shenzhen 518110, China.
Tao LiDepartment of Critical Care Medicine, The First People's Hospital of Chenzhou, Institute of Translation Medicine Chenzhou 423000, China.
Kai ZengDepartment of Anesthesiology, The First Affiliated Hospital of Fujian Medical University Fuzhou 350005, China.
Shumin CaiDepartment of Critical Care Medicine, Nanfang Hospital, Southern Medical University Guangzhou 510515, China.
Zhenhua ZengDepartment of Critical Care Medicine, Nanfang Hospital, Southern Medical University Guangzhou 510515, China.
Caizhu LinDepartment of Anesthesiology, The First Affiliated Hospital of Fujian Medical University Fuzhou 350005, China.
Zhongqing ChenDepartment of Critical Care Medicine, Nanfang Hospital, Southern Medical University Guangzhou 510515, China.
Youguang GaoDepartment of Anesthesiology, The First Affiliated Hospital of Fujian Medical University Fuzhou 350005, China.
Fujian Medical University · CNSouthern Medical University · CNChenzhou First People's Hospital · CNSouthern Medical University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectRecent studies have suggested that intrinsic apoptotic signaling cascade is involved in endothelial barrier dysfunction following hemorrhagic shock (HS), which results in vascular hyperpermeability. Our previous study demonstrated that ulinastatin (UTI) inhibits oxidant-induced endothelial hyperpermeability and apoptotic signaling. In present study, we hypothesized that UTI would improve HS-induced vascular hyperpermeability by regulating the intrinsic apoptotic signaling cascade.

methodsHemorrhagic shock was induced in rats by withdrawing blood to reduce the mean arterial pressure to 40-45 mmHg for 60 min, followed by reperfusion. Mesenteric postcapillary venules were examined for changes in hyperpermeability by intravital microscopy. In vitro, Rat lung microvascular endothelial cells (RLMVECs) were exposed in hemorrhagic shock serum for 120 min, followed by transendothelial electrical resistance (TER) estimation. Mitochondrial release of cytochrome c and caspase-3 activation was estimated in vivo. In vitro, ratio of cell apoptosis was evaluated by Annexin-V/PI double stain assay; mitochondrial membrane potential (∆Ψm) was determined with JC-1; intracellular ATP content was assayed by a commercial kit; reactive oxygen species (ROS) was measured by DCFH-DA; adherens junction protein β-catenin was detected by immunofluorescense staining.

resultsIn vivo, UTI attenuated HS-induced vascular hyperpermeability versus the HS group (P < 0.05); In vitro, UTI attenuated shock serum induced RLMEC monolayer hyperpermeability (P < 0.05). In vivo, UTI inhibited HS-induced cytochrome c release and caspase-3 activation (P < 0.05). In vitro, shock serum induced cell apoptosis, low ATP level, ∆Ψm depolarization, ROS increase were improved by UTI pre-treatment (P < 0.05). UTI improved shock serum induced disruption of endothelial cell adherens junction.

conclusionsUTI inhibits vascular hyperpermeability following HS. UTI regulates oxidative stress and intrinsic apoptotic signaling following HS.

Indexed as

Signal TransductionAnimalsApoptosisBenzimidazolesbeta CateninCapillary PermeabilityCarbocyaninesCaspase 3Cytochromes cEndothelial CellsFluoresceinsGlycoproteinsHumansMaleMembrane Potential, MitochondrialMesentery5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanineBenzimidazolesbeta CateninCarbocyaninesCaspase 3Cytochromes cdiacetyldichlorofluoresceinFluoresceinsGlycoproteinsReactive Oxygen SpeciesTrypsin InhibitorsurinastatinapoptosisHemorrhagic shockhyperpermeabilitymitochondriaulinastatin

Identifiers

PMID26339335
PMCPMC4555663
OpenAlexW1442866520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.